Current progress in using vitamin D and its analogs for cancer prevention and treatment
- PMID: 22716497
- DOI: 10.1586/era.12.53
Current progress in using vitamin D and its analogs for cancer prevention and treatment
Abstract
Vitamin D has long been known for its physiological role in mineral homeostasis through its actions on the intestines, kidneys, parathyroid glands and bone. However, recent observations of antiproliferative, prodifferentiating and antiangiogenic effects elicited by the bioactive form of vitamin D (1,25[OH](2)D(3)) in a broad range of cancers is less well understood. Here, we review the increasing epidemiological and experimental evidence that supports the development of 1,25(OH)(2)D(3) and vitamin D analogs as preventative and therapeutic anticancer agents. Furthermore, this review summarizes the preclinical and clinical studies of vitamin D and its analogs over the past decade, indicating the current problems of dose-limiting toxicity from hypercalcemia and large interpatient variability in pharmacokinetics. A better understanding of how genetic variants influence vitamin D status should not only improve cancer risk predictions, but also promote the development of vitamin D analogs with more specific actions to improve therapeutic outcomes.
Similar articles
-
Vitamin D analogs: therapeutic applications and mechanisms for selectivity.Mol Aspects Med. 2008 Dec;29(6):433-52. doi: 10.1016/j.mam.2008.04.001. Epub 2008 May 1. Mol Aspects Med. 2008. PMID: 18554710 Review.
-
Vitamin D compounds: clinical development as cancer therapy and prevention agents.Anticancer Res. 2006 Jul-Aug;26(4A):2551-6. Anticancer Res. 2006. PMID: 16886663
-
Vitamin D analogs in cancer prevention and therapy.Anticancer Res. 2006 Jul-Aug;26(4A):2511-4. Anticancer Res. 2006. PMID: 16886658
-
Cancer chemoprevention using natural vitamin D and synthetic analogs.Annu Rev Pharmacol Toxicol. 2001;41:421-42. doi: 10.1146/annurev.pharmtox.41.1.421. Annu Rev Pharmacol Toxicol. 2001. PMID: 11264464 Review.
-
Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.CMAJ. 1996 Oct 1;155(7):955-61. CMAJ. 1996. PMID: 8837546 Free PMC article. Review.
Cited by
-
Vitamin D and urological cancers.Cent European J Urol. 2016;69(2):139-47. doi: 10.5173/ceju.2016.784. Epub 2016 Apr 19. Cent European J Urol. 2016. PMID: 27551550 Free PMC article. Review.
-
Induced myelomonocytic differentiation in leukemia cells is accompanied by noncanonical transcription factor expression.FEBS Open Bio. 2015 Sep 28;5:789-800. doi: 10.1016/j.fob.2015.09.008. eCollection 2015. FEBS Open Bio. 2015. PMID: 26566473 Free PMC article.
-
Prodifferentiation Activity of Novel Vitamin D₂ Analogs PRI-1916 and PRI-1917 and Their Combinations with a Plant Polyphenol in Acute Myeloid Leukemia Cells.Int J Mol Sci. 2016 Jul 5;17(7):1068. doi: 10.3390/ijms17071068. Int J Mol Sci. 2016. PMID: 27399677 Free PMC article.
-
Effects of vitamin D3 stimulation of thioredoxin-interacting protein in hepatocellular carcinoma.Hepatol Res. 2014 Dec;44(13):1357-66. doi: 10.1111/hepr.12302. Epub 2014 Mar 25. Hepatol Res. 2014. PMID: 24451003 Free PMC article.
-
Serum vitamin D3 levels are not associated with thyroid cancer prevalence in euthyroid subjects without autoimmune thyroid disease.Korean J Intern Med. 2017 Jan;32(1):102-108. doi: 10.3904/kjim.2015.090. Epub 2016 Sep 1. Korean J Intern Med. 2017. PMID: 27581957 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
